England to Limit Gatherings; Vaccine Safety Pledge: Virus Update

Frontrunners in the race for a Covid-19 vaccine pledged to avoid shortcuts on science as they face pressure to rush a shot to market. AstraZeneca Plc put its Phase 3 study on hold after a suspected adverse reaction, STAT reported.